The fact our cells are a defined consistent reproducible product, shows again they are preferred to alternatives (there really is no others), underlines the real value of our company, not accounted for on the asx presently. Things will progress.....
Ann: Grant Award to Fund Study of Cynata MSCs in Heart Disease, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.010(6.06%) |
Mkt cap ! $39.54M | |||
| Open | High | Low | Value | Volume |
| 17.5¢ | 18.0¢ | 17.5¢ | $29.83K | 169.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 36293 | 17.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 150916 | 9 |
View Market Depth
| Last trade - 13.02pm 28/07/2025 (20 minute delay) ? |
| CYP (ASX) Chart |